141 related articles for article (PubMed ID: 24333731)
1. LRH1 as a driving factor in pancreatic cancer growth.
Lin Q; Aihara A; Chung W; Li Y; Huang Z; Chen X; Weng S; Carlson RI; Wands JR; Dong X
Cancer Lett; 2014 Apr; 345(1):85-90. PubMed ID: 24333731
[TBL] [Abstract][Full Text] [Related]
2. LRH1 promotes pancreatic cancer metastasis.
Lin Q; Aihara A; Chung W; Li Y; Chen X; Huang Z; Weng S; Carlson RI; Nadolny C; Wands JR; Dong X
Cancer Lett; 2014 Aug; 350(1-2):15-24. PubMed ID: 24769073
[TBL] [Abstract][Full Text] [Related]
3. RREB1-induced upregulation of the lncRNA AGAP2-AS1 regulates the proliferation and migration of pancreatic cancer partly through suppressing ANKRD1 and ANGPTL4.
Hui B; Ji H; Xu Y; Wang J; Ma Z; Zhang C; Wang K; Zhou Y
Cell Death Dis; 2019 Feb; 10(3):207. PubMed ID: 30814490
[TBL] [Abstract][Full Text] [Related]
4. The long noncoding RNA H19 promotes cell proliferation via E2F-1 in pancreatic ductal adenocarcinoma.
Ma L; Tian X; Wang F; Zhang Z; Du C; Xie X; Kornmann M; Yang Y
Cancer Biol Ther; 2016 Oct; 17(10):1051-1061. PubMed ID: 27573434
[TBL] [Abstract][Full Text] [Related]
5. Calreticulin promotes EGF-induced EMT in pancreatic cancer cells via Integrin/EGFR-ERK/MAPK signaling pathway.
Sheng W; Chen C; Dong M; Wang G; Zhou J; Song H; Li Y; Zhang J; Ding S
Cell Death Dis; 2017 Oct; 8(10):e3147. PubMed ID: 29072694
[TBL] [Abstract][Full Text] [Related]
6. High Expression of Cell Division Cycle 42 Promotes Pancreatic Cancer Growth and Predicts Poor Outcome of Pancreatic Cancer Patients.
Yang D; Zhang Y; Cheng Y; Hong L; Wang C; Wei Z; Cai Q; Yan R
Dig Dis Sci; 2017 Apr; 62(4):958-967. PubMed ID: 28181096
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia but not normoxia promotes Smoothened transcription through upregulation of RBPJ and Mastermind-like 3 in pancreatic cancer.
Onishi H; Yamasaki A; Kawamoto M; Imaizumi A; Katano M
Cancer Lett; 2016 Feb; 371(2):143-50. PubMed ID: 26655998
[TBL] [Abstract][Full Text] [Related]
8. The loss of miR-26a-mediated post-transcriptional regulation of cyclin E2 in pancreatic cancer cell proliferation and decreased patient survival.
Deng J; He M; Chen L; Chen C; Zheng J; Cai Z
PLoS One; 2013; 8(10):e76450. PubMed ID: 24116110
[TBL] [Abstract][Full Text] [Related]
9. CLK1/SRSF5 pathway induces aberrant exon skipping of METTL14 and Cyclin L2 and promotes growth and metastasis of pancreatic cancer.
Chen S; Yang C; Wang ZW; Hu JF; Pan JJ; Liao CY; Zhang JQ; Chen JZ; Huang Y; Huang L; Zhan Q; Tian YF; Shen BY; Wang YD
J Hematol Oncol; 2021 Apr; 14(1):60. PubMed ID: 33849617
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic stellate cells derived exosomal miR-5703 promotes pancreatic cancer by downregulating CMTM4 and activating PI3K/Akt pathway.
Li M; Guo H; Wang Q; Chen K; Marko K; Tian X; Yang Y
Cancer Lett; 2020 Oct; 490():20-30. PubMed ID: 32585413
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of Nodal induces a metastatic phenotype in pancreatic cancer cells via the Smad2/3 pathway.
Duan W; Li R; Ma J; Lei J; Xu Q; Jiang Z; Nan L; Li X; Wang Z; Huo X; Han L; Wu Z; Wu E; Ma Q
Oncotarget; 2015 Jan; 6(3):1490-506. PubMed ID: 25557170
[TBL] [Abstract][Full Text] [Related]
12. Hippo transducer TAZ promotes epithelial mesenchymal transition and supports pancreatic cancer progression.
Xie D; Cui J; Xia T; Jia Z; Wang L; Wei W; Zhu A; Gao Y; Xie K; Quan M
Oncotarget; 2015 Nov; 6(34):35949-63. PubMed ID: 26416426
[TBL] [Abstract][Full Text] [Related]
13. Effects of Raf kinase inhibitor protein expression on pancreatic cancer cell growth and motility: an in vivo and in vitro study.
Dai H; Chen H; Liu W; You Y; Tan J; Yang A; Lai X; Bie P
J Cancer Res Clin Oncol; 2016 Oct; 142(10):2107-17. PubMed ID: 27444299
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA SOX2OT promotes the proliferation of pancreatic cancer by binding to FUS.
Chen L; Zhang J; Chen Q; Ge W; Meng L; Huang X; Shen P; Yuan H; Shi G; Miao Y; Jiang K
Int J Cancer; 2020 Jul; 147(1):175-188. PubMed ID: 31837005
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer.
Von Marschall Z; Scholz A; Stacker SA; Achen MG; Jackson DG; Alves F; Schirner M; Haberey M; Thierauch KH; Wiedenmann B; Rosewicz S
Int J Oncol; 2005 Sep; 27(3):669-79. PubMed ID: 16077915
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA 00976 promotes pancreatic cancer progression through OTUD7B by sponging miR-137 involving EGFR/MAPK pathway.
Lei S; He Z; Chen T; Guo X; Zeng Z; Shen Y; Jiang J
J Exp Clin Cancer Res; 2019 Nov; 38(1):470. PubMed ID: 31747939
[TBL] [Abstract][Full Text] [Related]
17. CircFOXK2 Promotes Growth and Metastasis of Pancreatic Ductal Adenocarcinoma by Complexing with RNA-Binding Proteins and Sponging MiR-942.
Wong CH; Lou UK; Li Y; Chan SL; Tong JH; To KF; Chen Y
Cancer Res; 2020 Jun; 80(11):2138-2149. PubMed ID: 32217695
[TBL] [Abstract][Full Text] [Related]
18. CLPTM1L promotes growth and enhances aneuploidy in pancreatic cancer cells.
Jia J; Bosley AD; Thompson A; Hoskins JW; Cheuk A; Collins I; Parikh H; Xiao Z; Ylaya K; Dzyadyk M; Cozen W; Hernandez BY; Lynch CF; Loncarek J; Altekruse SF; Zhang L; Westlake CJ; Factor VM; Thorgeirsson S; Bamlet WR; Hewitt SM; Petersen GM; Andresson T; Amundadottir LT
Cancer Res; 2014 May; 74(10):2785-95. PubMed ID: 24648346
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of PD2 leads to increased tumorigenicity and metastasis in pancreatic ductal adenocarcinoma.
Vaz AP; Deb S; Rachagani S; Dey P; Muniyan S; Lakshmanan I; Karmakar S; Smith L; Johansson S; Lele S; Ouellette M; Ponnusamy MP; Batra SK
Oncotarget; 2016 Jan; 7(3):3317-31. PubMed ID: 26689992
[TBL] [Abstract][Full Text] [Related]
20. Dickkopf-1 is overexpressed in human pancreatic ductal adenocarcinoma cells and is involved in invasive growth.
Takahashi N; Fukushima T; Yorita K; Tanaka H; Chijiiwa K; Kataoka H
Int J Cancer; 2010 Apr; 126(7):1611-20. PubMed ID: 19711349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
